Patienter med nedsat nyrefunktion Der er ikke påvist, at tolerancen reduceres i forbindelse med en øgning i eksponeringen af ibandronat hos patienter med forskellige grader af nedsat nyrefunktion.
Patients with renal impairment There is no evidence of a reduction in tolerability associated with an increase in exposure to ibandronate in patients with various degrees of renal impairment.